瑞典Mabtech  
Mabtech公司成立于1986年，最初源自瑞典斯德哥尔摩大学免疫学系，目前已成为ELISpot和T细胞检测技术的全球领先者。ELISPO是当今最灵敏和最简便的特异性T细胞应答分析技术之一，是探讨感染、癌症、过敏和自身免疫性疾病等诸多病症中T细胞功能最为理想的研究手段。因其具有结果直观和适于高通量检测等优点，业已成为新疫苗实验研究和临床评价的标准方法。
作为ELISpot产品的补充，Mabtech公司近期推出了一系列即用型细胞因子ELISA试剂盒，可以方便、准确地检测血清和血浆等多种样品中的细胞因子水平。
Mabtech公司以卓尔不群的创新能力和稳定可靠的产品质量，不断开发出适应前沿科学研究和临床大规模筛选需求的优质产品。Mabtech公司依靠一支精干和敬业的团队，为用户提供最好的产品和最佳的技术服务。除位于斯德哥尔摩的公司总部和研究实验室，Mabtech公司在澳大利亚、法国、德国和美国均设有办事处，与全球高端科研机构保持紧密的合作并为全球用户提供快捷的物流。
Mabtech公司提供多种高品质的ELISA和ELISpot试剂盒，用于检测多种种属细胞因子和相关的免疫效应分子。Mabtech公司的抗体也可单独包装，供用户进行流式细胞术和免疫细胞化学等实验研究。

Mabtech AB is a privately owned biotech company founded in 1986. Emerging from the Department of Immunology at Stockholm University, Mabtech has become a world leader in ELISpot and T-cell measurements.

Representing one of the most sensitive and easiest methods to analyze specific T-cell responses, the ELISpot is ideal whenever studying the role of T cells in e.g. infections, cancer, allergy and autoimmune disease. With its straightforward performance and the possibility to screen large number of samples, the ELISpot has become a standard method in the research and clinical evaluations of new vaccines.

To supplement the ELISpot products, we have recently launched a series of complete, ready-to-use ELISA kits that allow easy measurements of cytokine levels in various samples including serum and plasma.

By combining innovative development and high quality, our aim is to continue providing products that meet the needs of the frontline researcher as well as those involved in clinical research with high demands for large scale screening under standardized conditions.

With a highly competent and dedicated staff, we strive to always offer the best quality products and the best possible technical support. The head office and research laboratory are located in Stockholm but in order to work closely with the research community and to be able to offer fast deliveries world-wide we also have local offices in Australia, France, Germany and the USA. In several other countries we work via selected distributors.